Bernhard J. Eigl

10.2k citations
131 papers · 4.5k · 3 hit papers · h-index 28

Impact in

Papers in

    • Prostate Cancer Treatment and Research 43
    • Renal cell carcinoma treatment 13
    • Sarcoma Diagnosis and Treatment 9
    • Bladder and Urothelial Cancer Treatments 32
    • Testicular diseases and treatments 10

Bernhard J. Eigl

122 papers receiving 4.5k citations

Bernhard J. Eigl's Hit Papers

Optimal sequencing of enzalutamide and abiraterone acetate plus prednisone in metastatic castration-resistant prostate cancer: a multicentre, randomised, open-label, phase 2, crossover trial 2019 · 218 citations
2180+5+11Years since publication50010001.5k

Peers

Bernhard J. Eigl
Comparison fields: 5 of 103
  • Pulmonary and Respiratory Medicine 2.7k
  • Cancer Research 969
  • Oncology 1.0k
  • Molecular Biology 1.1k
  • Surgery 619
Replace Roberto Iacovelli with:
Roberto Iacovelli Italy
Lauren C. Harshman United States
R. Bryan Rumble United States
Vincenza Conteduca Italy
Stéphane Culine France
Tracy Curley United States
Simon Chowdhury United Kingdom
Ranee Mehra United States
Antoine Thiery-Vuillemin France
Bruce J. Giantonio United States
Bernhard J. Eigl relative to Roberto Iacovelli Italy Roberto Iacovelli's profile →
Citations per field
00.5×1.5×
Roberto Iacovelli · 1×
Citations per year

Countries citing papers authored by Bernhard J. Eigl

Since Specialization
Citations

This map shows the geographic impact of Bernhard J. Eigl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bernhard J. Eigl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bernhard J. Eigl more than expected).

Fields of papers citing papers by Bernhard J. Eigl

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bernhard J. Eigl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bernhard J. Eigl. The network helps show where Bernhard J. Eigl may publish in the future.

Co-authors

The 25 scholars most cited alongside Bernhard J. Eigl, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Bernhard J. Eigl Line = papers co-authored together Bernhard J. Eigl links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 131 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Prognostic Factors for Overall Survival in Patients With Metastatic Renal Cell Carcinoma Treated With Vascular Endothelial Growth Factor–Targeted Agents: Results From a Large, Multicenter Study
Hit paper breakdown →
20091545
2
Circulating Tumor DNA Genomics Correlate with Resistance to Abiraterone and Enzalutamide in Prostate Cancer
Hit paper breakdown →
2018353
3
Optimal sequencing of enzalutamide and abiraterone acetate plus prednisone in metastatic castration-resistant prostate cancer: a multicentre, randomised, open-label, phase 2, crossover trial
Hit paper breakdown →
2019218
4 2010179
5 2013144
6 2015132
7 2014132
8 2017124
9 2021116
10 200588
11 201678
12 200862
13 201859
14 201558
15 202156
16 200552
17 201348
18 202047
19 201443
20 200640

About Bernhard J. Eigl

Bernhard J. Eigl is a scholar working on Pulmonary and Respiratory Medicine, Surgery, Oncology, Molecular Biology and Cancer Research, having authored 131 papers that have together received 4.5k indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (43 papers), Bladder and Urothelial Cancer Treatments (32 papers), Cancer Genomics and Diagnostics (14 papers), Radiopharmaceutical Chemistry and Applications (14 papers), Renal cell carcinoma treatment (13 papers), Testicular diseases and treatments (10 papers), Sarcoma Diagnosis and Treatment (9 papers) and Cancer Treatment and Pharmacology (8 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (2.7k citations), Cancer Research (969 citations), Oncology (1.0k citations), Molecular Biology (1.1k citations) and Surgery (619 citations). Bernhard J. Eigl has collaborated with scholars based in Canada, United States and United Kingdom. Frequent co-authors include Kim N., Christian Kollmannsberger, Scott North, Peter Venner, Martin Gleave, Daniel Y.C. Heng, Arun Azad, Jennifer J. Knox, Joseph D. Ruether and Tina Cheng. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, Clinical Cancer Research, European Urology and Clinical Genitourinary Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact